Publications
- Significance of plasma fibrinogen and malondialdehyde in the post-inflammatory period in patients with cystic fibrosis2022 | Second Faculty of Medicine, First Faculty of Medicine
- Mapping of the lung megakaryocytes: A role in pathogenesis of idiopathic pulmonary arterial hypertension?2022 | Second Faculty of Medicine, First Faculty of Medicine
- Acute portal vein thrombosis in noncirrhotic patients - different prognoses based on presence of inflammatory markers: a long-term multicenter retrospective analysis2019 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Medicine in Pilsen, Central Library of Charles University, Third Faculty of Medicine
- The significance of plasma adrenomedullin and calcitonin gene-related peptide concentration in patients with Type 2 diabetes mellitus who are treated for cardiovascular risk factors2014 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Population pharmacokinetics and covariate-based dosing individualization of voriconazole in lung transplant recipients2024 | Second Faculty of Medicine, First Faculty of Medicine
- Effect of SARS-CoV-2 infection on anti-HLA antibodies and de novo donor specific antibodies incidence in lung transplant recipients2023 | Second Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
- Defining a NK cell-enriched molecular rejection-like state in lung transplant transbronchial biopsies2023 | Second Faculty of Medicine, Central Library of Charles University
- Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model2023 | Second Faculty of Medicine, First Faculty of Medicine
- Demonstration of the Rationale for Therapeutic Drug Monitoring of Isavuconazole: A Case Report with a Lung Transplant Recipient2023 | Second Faculty of Medicine, First Faculty of Medicine
- A patient with pulmonary hypertension waiting for donor lungs during the pandemic: 194 days on extracorporeal life support including 143 days on pulmonary artery to left atrium shunt2022 | Second Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
Loading network view...